Caractérisation de la réponse immune induite par un adjuvant comprenant un agoniste du TLR4 dans des modèles murins

Caractérisation de la réponse immune induite par un adjuvant comprenant un agoniste du TLR4 dans des modèles murins

En 2014 la Tuberculose (TB) à dépassé le VIH comme la principale cause de décès par maladie infectieuse dans le monde soulignant le besoin urgent de développer un vaccin plus efficace contre cette maladie. Le candidat vaccin contre la TB, ID93/GLA-SE, dévéloppé à l’Infectious Disease Research Instit...

Full description

Bibliographic Details
Main Author:	Dubois, Natasha
Other Authors:	Université Paris-Saclay (ComUE)
Language:	en
Published:	2016
Subjects:	Adjuvant Tlr4 Th1 Lymphocytes B Innée Adaptative B cells Innate
Online Access:	http://www.theses.fr/2016SACLS131/document

Similar Items

Reactivating Immunity Primed by Acellular Pertussis Vaccines in the Absence of Circulating Antibodies: Enhanced Bacterial Control by TLR9 Rather Than TLR4 Agonist-Including Formulation
by: Floriane Auderset, et al.
Published: (2019-07-01)

DNA-Encoded Flagellin Activates Toll-Like Receptor 5 (TLR5), Nod-like Receptor Family CARD Domain-Containing Protein 4 (NRLC4), and Acts as an Epidermal, Systemic, and Mucosal-Adjuvant
by: Steven E. Applequist, et al.
Published: (2013-09-01)

Molecular Signatures of a TLR4 Agonist-Adjuvanted HIV-1 Vaccine Candidate in Humans
by: Jenna Anderson, et al.
Published: (2018-02-01)

CD169+ Subcapsular Macrophage Role in Antigen Adjuvant Activity
by: Christina Lisk, et al.
Published: (2021-03-01)

Toll-Like Receptor Ligand Based Adjuvant, PorB, Increases Antigen Deposition on Germinal Center Follicular Dendritic Cells While Enhancing the Follicular Dendritic Cells Network
by: Christina Lisk, et al.
Published: (2020-06-01)

New chimeric TLR7/NOD2 agonist is a potent adjuvant to induce mucosal immune responses
by: Alice Gutjahr, et al.
Published: (2020-08-01)

Silencing SOCS1 via Liposome-Packed siRNA Sustains TLR4-Ligand Adjuvant
by: Dagmar Hildebrand, et al.
Published: (2019-06-01)

A Novel Synthetic Dual Agonistic Liposomal TLR4/7 Adjuvant Promotes Broad Immune Responses in an Influenza Vaccine With Minimal Reactogenicity
by: Fumi Sato-Kaneko, et al.
Published: (2020-06-01)

Immunological responses and mechanisms of action of the TLR2-ligand Neisserial PorB vaccine adjuvant
by: Mosaheb, Munir
Published: (2016)

Polysaccharide Isolated From Tetrastigma hemsleyanum Activates TLR4 in Macrophage Cell Lines and Enhances Immune Responses in OVA-Immunized and LLC-Bearing Mouse Models
by: Fang-mei Zhou, et al.
Published: (2021-03-01)

Bacterial Protein Toll-Like-Receptor Agonists: A Novel Perspective on Vaccine Adjuvants
by: Sudeep Kumar, et al.
Published: (2019-05-01)

Surface Immunogenic Protein of <i>Streptococcus</i> Group B is an Agonist of Toll-Like Receptors 2 and 4 and a Potential Immune Adjuvant
by: Diego A. Diaz-Dinamarca, et al.
Published: (2020-01-01)

Harnessing the Induction of CD8+ T-Cell Responses Through Metabolic Regulation by Pathogen-Recognition-Receptor Triggering in Antigen Presenting Cells
by: Francesco Nicoli, et al.
Published: (2018-10-01)

TLR4-dependent effects of ISAg treatment on conventional T cell polarization in vivo
by: Sung Won Lee, et al.
Published: (2019-05-01)

A novel function of API5 (apoptosis inhibitor 5), TLR4-dependent activation of antigen presenting cells
by: Young Seob Kim, et al.
Published: (2018-10-01)

MPL Adjuvant Contains Competitive Antagonists of Human TLR4
by: Yi-Qi Wang, et al.
Published: (2020-10-01)

Exploration of Pattern Recognition Receptor Agonists as Candidate Adjuvants
by: Guang Han Ong, et al.
Published: (2021-10-01)

A new synthetic toll-like receptor 1/2 ligand is an efficient adjuvant for peptide vaccination in a human volunteer
by: Hans-Georg Rammensee, et al.
Published: (2019-11-01)

Up-regulation of TLR2 and TLR4 in high mobility group Box1-stimulated macrophages in pulpitis patients
by: Javad Mahmoudi, et al.
Published: (2017-02-01)

Adjuvantation of an Influenza Hemagglutinin Antigen with TLR4 and NOD2 Agonists Encapsulated in Poly(D,L-Lactide-Co-Glycolide) Nanoparticles Enhances Immunogenicity and Protection against Lethal Influenza Virus Infection in Mice
by: Amir Tukhvatulin, et al.
Published: (2020-09-01)

Novel Lipidated Imidazoquinoline TLR7/8 Adjuvants Elicit Influenza-Specific Th1 Immune Responses and Protect Against Heterologous H3N2 Influenza Challenge in Mice
by: Shannon M. Miller, et al.
Published: (2020-03-01)

Agonists of Receptors of the Innate Immunity and Defective Viral Particles as New Generation of Adjuvants
by: O. A. Svitich, et al.
Published: (2018-02-01)

Pam3CSK4 enhances adaptive immune responses to recombinant Mycobacterium bovis bacille Calmette-Guérin expressing Plasmodium falciparum C-terminus merozoite surface protein-1
by: Mohamed H Abdikarim, et al.
Published: (2019-01-01)

Role of Mal/TIRAP in TLR2- and TLR4-, but not TLR5-Induced Corneal Inflammation
by: Williams, Susan R.
Published: (2010)

TLR4 expression on equine B lymphocytes: a clue to LPS sensitivity?
by: Kasmark, Leah
Published: (2017)

Subcutaneous Immunization with Fusion Protein DnaJ-ΔA146Ply without Additional Adjuvants Induces both Humoral and Cellular Immunity against Pneumococcal Infection Partially Depending on TLR4
by: Yufeng Su, et al.
Published: (2017-06-01)

Effect of ligustrazine nanoparticles on Th1/Th2 balance by TLR4/MyD88/NF-κB pathway in rats with postoperative peritoneal adhesion
by: Lili Yang, et al.
Published: (2021-04-01)

Effect and mechanism of N - acetylcysteine on adjuvant arthritis rats
by: Jun Yang, et al.
Published: (2021-07-01)

TLR9 Signaling Suppresses the Canonical Plasma Cell Differentiation Program in Follicular B Cells
by: Bárbara José Antunes Baptista, et al.
Published: (2018-11-01)

A peptide array for bovine-specific Kinome analysis : comparative analysis of bovine monocytes activated by TLR4 and TLR9 agonists
by: Jalal, Shakiba
Published: (2008)

Immunological Evaluation of Recent MUC1 Glycopeptide Cancer Vaccines
by: Md Kamal Hossain, et al.
Published: (2016-07-01)

Immune Adjuvant Effect of Molecularly-defined Toll-Like Receptor Ligands
by: Deana N. Toussi, et al.
Published: (2014-04-01)

Immunomodulation of TLR2 and TLR4 by G2013 (alfa-L-Guluronic acid) in CVID Patients
by: Laleh Sharifi, et al.
Published: (2017-07-01)

Adjuvants Enhancing Cross-Presentation by Dendritic Cells: The Key to More Effective Vaccines?
by: Nataschja I. Ho, et al.
Published: (2018-12-01)

Tailored Modulation of Cellular Pro-inflammatory Responses With Disaccharide Lipid A Mimetics
by: Holger Heine, et al.
Published: (2021-03-01)

The Transcription Factor SUB1 Is a Master Regulator of the Macrophage TLR Response in Atherosclerosis
by: Rongzhong Huang, et al.
Published: (2021-10-01)

Adjuvant effect of docetaxel on the immune responses to influenza A H1N1 vaccine in mice
by: Chen Jian, et al.
Published: (2012-07-01)

Characterization of the molecular mechanisms of Epstein-Barr Virus-mediated inhibition of the innate sensor TLR9
by: Fathallah, Ikbal
Published: (2009)

Rehmannia glutinosa polysaccharide induces toll-like receptor 4 dependent spleen dendritic cell maturation and anti-cancer immunity
by: Li Xu, et al.
Published: (2017-07-01)

P-MAPA immunotherapy potentiates the effect of cisplatin on serous ovarian carcinoma through targeting TLR4 signaling
by: Luiz Gustavo de Almeida Chuffa, et al.
Published: (2018-01-01)